Taiwan Semiconductor Manufacturing on Track for Highest Close Since January 2022 — Data Talk
Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM) is currently at $135.93, up $7.26 or 5.64%
--Would be highest close since Jan. 14, 2022, when it closed at $140.66
--On pace for largest percent increase since Feb. 8, 2024, when it rose 7%
--Currently up two consecutive days; up 6.71% over this period
--Best two day stretch since the two days ending Feb. 8, 2024, when it rose 12.02%
--Up 30.7% year-to-date
--Down 3.36% from its all-time closing high of $140.66 on Jan. 14, 2022
--Up 51.39% from 52 weeks ago (March 3, 2023), when it closed at $89.79
--Would be a new 52-week closing high
--Up 65.26% from its 52-week closing low of $82.25 on April 26, 2023
--Traded as high as $136.65; highest intraday level since Jan. 18, 2022, when it hit $137.18
--Up 6.2% at today's intraday high; largest intraday percent increase since Feb. 8, 2024, when it rose as much as 7.82%
All data as of 1:28:13 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 01, 2024 13:45 ET (18:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track